Haematologica (Jun 2024)
<i>ASXL1/TET2</i> genotype-based risk stratification outperforms <i>ASXL1</i> mutational impact and is independent of mutant variant allele fractions in chronic myelomonocytic leukemia
- Clifford M. Csizmar,
- Mark Gurney,
- Rashmi Kanagal-Shamanna,
- Kelly Chien,
- Danielle Hammond,
- Terra L. Lasho,
- Christy M. Finke,
- Christopher Dean,
- Anuya Natu,
- Abhishek A. Mangaonkar,
- Aref Al-Kali,
- Naseema Gangat,
- Ayalew Tefferi,
- Hassan Alkhateeb,
- Guillermo Garcia-Manero,
- Rami S. Komrokji,
- Najla A. Ali,
- Eric Padron,
- Guillermo Montalban-Bravo,
- Mrinal M. Patnaik
Affiliations
- Clifford M. Csizmar
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- Mark Gurney
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- Rashmi Kanagal-Shamanna
- Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
- Kelly Chien
- Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
- Danielle Hammond
- Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
- Terra L. Lasho
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- Christy M. Finke
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- Christopher Dean
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- Anuya Natu
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- Abhishek A. Mangaonkar
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- Aref Al-Kali
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- Naseema Gangat
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- Ayalew Tefferi
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- Hassan Alkhateeb
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- Guillermo Garcia-Manero
- Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
- Rami S. Komrokji
- Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
- Najla A. Ali
- Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
- Eric Padron
- Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
- Guillermo Montalban-Bravo
- Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
- Mrinal M. Patnaik
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
- DOI
- https://doi.org/10.3324/haematol.2024.285410
- Journal volume & issue
-
Vol. 999,
no. 1
Abstract
Not available.
